VR Logo

Veru Inc. (VERU) download report


Healthcare | Biotechnology & Pharma Research

Veru Inc. (VERU) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers.

IPO Date: 19-Jul-1990

Chairman, Pres & CEO: Dr. Mitchell S. Steiner F.A.C.S, F.A.C.S., M.D.

Vice Chairman & Chief Corp. Officer: Dr. Harry Fisch F.A.C.S., M.D.

Listing: NASDAQ: VERU

Country: United States

Headquarters: Miami, FL

Website: https://www.verupharma.com

Key Facts

Market cap: $1,009.73 Mln

Revenue (TTM): $60.47 Mln

Earnings (TTM): $-27.55 Mln

Cash: $112.02 Mln

Total Debt: $20.24 Mln

Insider's Holding: 19.48%

Liquidity: Low

52 Week range: $4.34 - 17.77

Shares outstanding: 80,073,696

10 Years Aggregate:

  • CFO: $-11.00 Mln
  • EBITDA: $-3.83 Mln
  • Net Profit: $-17.38 Mln

Stock Performance

Time Period Veru (VERU) S&P BSE Sensex* S&P Small-Cap 600*
YTD114.090.66-11.58
1 month12.598.238.86
3 months33.866.93-2.19
1 Year82.498.03-6.23
3 Years79.2416.929.73
5 Years58.5112.687.72
10 Years8.1412.7910.81
As on 05-Aug-2022 *As on 08-Aug-2022
Year Veru (VERU) S&P Small-Cap 600 S&P BSE Sensex
2021-31.9125.2721.99
2020158.219.5715.75
2019139.2920.8614.38
201822.67-9.705.87
201725.2711.7327.91
2016-37.2424.741.95
2015-63.01-3.36-5.03